GET DAILY SIGNALSWhy Is American Public Education (APEI) Stock Up +6.63% Today?
Key Takeaways
- APEI shares climbed 6.63% to $41.68, up from a prior-session close of $39.09.
- The primary catalyst was a beat-and-raise third-quarter 2026 earnings report that topped guidance and lifted the full-year outlook.
- Secondary drivers included rebounding Military+ registrations and 9% growth in the Health+ nursing and healthcare segment.
- The move follows a prior-session gain, extending an earnings-driven rally in a volatile, smaller-cap education name.
- Traders are now watching fourth-quarter execution, margin recovery, and the timing of Title IV financial-aid disbursements.
- For more detail on valuation, you can explore the company's Price Targets, Earnings, and Forecast pages.
- For AI-driven trading ideas across thousands of tickers, explore Trending AI Robots.
Opening Summary
American Public Education, Inc. (APEI), a for-profit higher-education operator that runs American Military University, American Public University, Rasmussen University, and Hondros College of Nursing, saw its stock rally sharply on Tuesday. Shares advanced 6.63% to $41.68, building on the prior session's gain of roughly 4.9%. The move extends an earnings-driven surge after the company reported third-quarter 2026 results that beat guidance and raised its full-year forecast.
Earnings Beat and Raised Guidance
The dominant catalyst was a stronger-than-expected third quarter. APEI posted revenue of $169.1 million, up 3.6% year over year and above the top end of its guidance range of $164.5 million to $167 million. Diluted earnings per share came in at $0.32, ahead of the roughly $0.26 consensus and up 6.7% year over year. Net income available to common stockholders rose 6% to $5.9 million.
Just as important, management raised full-year 2026 guidance across revenue, net income, adjusted EBITDA, and diluted EPS. The company now projects full-year revenue of $695 million to $701 million and EPS of $2.59 to $2.84, up from its prior outlook. The upgraded forecast signaled confidence in fourth-quarter momentum and reinforced the bullish market reaction.
Segment Momentum and Enrollment Strength
Beneath the headline beat, investors focused on improving demand metrics. In the Military+ segment, net course registrations grew 3.8% to approximately 103,800, above guidance, with veteran and military-family registrations rising at double-digit rates and active-duty registrations returning to growth. Segment revenue was flat year over year, but management attributed roughly $6 million of the shortfall to a registration-timing shift into the fourth quarter rather than weakening demand.
The Health+ segment was the growth engine, with revenue up 9% to $86.4 million, driven by low-teens growth in campus nursing and mid-teens growth in online healthcare. While overall Health+ enrollment rose a more modest 2.5%, the mix shift toward higher-value nursing programs supported the revenue expansion.
Market Context and Trading Activity
The two-day advance reflects a classic earnings-driven repricing of a small- and mid-cap name that had sold off heading into the report. The stock had fallen roughly 19% over the prior month, leaving it positioned for a relief rally once results came in ahead of expectations. Trading volume was elevated relative to typical daily activity as investors repositioned following the announcement and the subsequent earnings call.
While the rally was primarily company-specific, it also unfolded against a backdrop of continued investor attention on education and healthcare-services names with improving enrollment trends. APEI outpaced the broader market, reflecting idiosyncratic news rather than broad index direction.
What Comes Next for APEI
Investors will now focus on whether the company can deliver the heavy fourth quarter embedded in its raised guidance, which implies a meaningful step-up in EPS versus the prior year. Key watch items include the pace of Military+ registration growth, the timing and resolution of temporary Title IV financial-aid disbursement delays that pressured cash flow and bad-debt expense, and continued execution of the Health+ campus expansion strategy.
Margin recovery remains a central question. Adjusted EBITDA margin narrowed to 10.4% from 12.7% a year earlier amid higher selling and promotional spending, and management must demonstrate that the company's marketing-optimization efforts and institutional-combination cost synergies translate into sustainable profitability. Risks include federal-policy exposure, potential government-shutdown disruptions, and any renewed softness in the non-healthcare Online+ enrollment business.
Trending AI Robots
Tickeron's Trending AI Robots page showcases a curated selection of AI-powered trading bots. Tickeron offers hundreds of bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this section. The bots vary by strategy, timeframe, performance metrics, and the symbols they trade. Explore the page to see which AI-driven strategies are currently leading the market.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.
APEI in downward trend: price dove below 50-day moving average on October 28, 2026
APEI moved below its 50-day moving average on October 28, 2026 date and that indicates a change from an upward trend to a downward trend. In 25 of 32 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 78%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on APEI as a result. In 63 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
The Moving Average Convergence Divergence Histogram (MACD) for APEI turned negative on October 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 30 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.
The 10-day moving average for APEI crossed bearishly below the 50-day moving average on November 03, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 77%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where APEI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where APEI's RSI Oscillator exited the oversold zone, 19 of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.97% 3-day Advance, the price is estimated to grow further. Considering data from situations where APEI advanced for three days, in 253 of 316 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
APEI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 216 of 281 cases where APEI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 62 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. APEI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 73 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.172) is normal, around the industry mean (1.158). P/E Ratio (14.912) is within average values for comparable stocks, (8.484). Projected Growth (PEG Ratio) (0.888) is also within normal values, averaging (1.327). Dividend Yield (0.000) settles around the average of (4.151) among similar stocks. P/S Ratio (1.252) is also within normal values, averaging (27.566).
The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of online post-secondary education
Industry OtherConsumerSpecialties
Advertisement